We demonstrate that a member of thefos family, thefosB gene, gives rise to two transcripts by alternative splicing of exon 4, generating two proteins, FosB of 338 amino acids and a short form, FosB/SF, which contains the DNA binding and dimerization domains but not the 101 amino acids of the C terminus. FosB/SF activates an AP-1-chloramphenicol acetyltransferase construct in NIH 3T3 cells, as determined by transient and stable transfections, although more weakly than does FosB. In contrast to FosB, FosB/SF has lost its ability to repress the dyad symmetry element of the c-fos gene. FosB/SF when expressed in excess to FosB can downmodulate the activity of FosB. Constitutive expression of high levels of FosB/SF in NIH 3T3 cells has no significant inhibitory effect in the induction of cell proliferation or cell cycle progression, indicating that FosB/SF is not a negative regulator of cell growth. This conclusion is further confirmed by the observation that the majority of the Jun molecules are complexed with FosB/SF in the FosB/SF-overexpressing cells.
The transcription factor AP-1, originally discovered in human cells as an activity that binds selectively to enhancer elements in the promoter region of simian virus 40 and of many other vertebrate genes (2, 27) , has been demonstrated to be a protein complex composed of different members of the Jun and Fos families (for a review, see reference 54). The first cellular gene identified to encode a transactivator similar to AP-1 was c-jun (1, 4) , the cellular homolog of the viral oncogene v-jun (31) . Two other members of this family,junB (44) and junD (16, 43) , have also been identified. A series of elegant studies has demonstrated that c-Jun and c-Fos form a complex in vivo that recognizes the AP-1 target sequence (54) . As in the case of c-jun, genes sharing a significant similarity with c-fos have also been described: fra-1 in rats (8) , fosB in mice (57) , andfra-2 in humans and chickens (33, 40) . The highly conserved common region of these families of proteins is composed of two structures: a basic motif, which is thought to bind directly to DNA, and a leucine zipper required for dimerization (6, 25) . The three Jun proteins, c-Jun, JunB, and JunD, can form homodimers and bind to an AP-1 site, but they differ in their binding affinities (46) , and it has been demonstrated that c-Jun and JunB have different transcriptional and biological activities (7, 51, 52) . The Fos proteins, c-Fos, FosB, Fra-1 and Fra-2, differ from the Jun proteins in that they do not form homodimers and have no intrinsic specific DNA binding activity (9, 13, 38, 57) . However, the binding affinity and transcriptional activation by the Jun proteins are dramatically increased upon dimerization with Fos proteins (1, 9, 13, 46, 57) . The complexity arising from the possible associations between different Jun and Jun:Fos proteins has been further increased by the finding that c-Jun can dimerize with other leucine zipper-containing proteins (3, 18, 30) .
Interestingly, the members ofjun (44, 45, 47) and fos (8, 12, 24, 36, 40, 57) families belong to the set of genes which are rapidly induced by growth factors in quiescent fibroblasts (5, 15, 26) , indicating that the Jun and Fos proteins may play an important role in the control of cell proliferation. It has been demonstrated that following serum stimulation of quiescent fibroblasts, different Jun:Fos heterodimers are formed and that their proportion is governed by their concentration (21) . A strong evidence that these proteins play an important role in normal cell growth is the observation that intracellular expression of antisense c-fos inhibits the entrance to the cell cycle of serum-stimulated quiescent cells (39) and cell cycle progression in exponentially growing cells (17) . This finding has been further supported by the fact that microinjection of anti-Fos (22, 42) and anti-Jun (22) antibodies efficiently inhibits induction of cell proliferation and cell cycle progression.
We have found that one of the members of the fos family, the fosB gene (57) , gives rise to two mRNA products by alternative splicing of exon 4, generating two FosB proteins, FosB and a shorter form, FosB/SF, which are simultaneously induced by serum in resting fibroblasts. While our work was in progress, Nakabeppu and Nathans (38) also demonstrated that the fosB gene gives rise to two mRNA products by alternative splicing. They showed that in transfection assays of F9 cells, the short form of FosB lost its capacity to activate a promoter with an AP-1 site and behaved like a dominant negative form of Fos in these cells. That Gels were dried and exposed to Kodak X-Omat AR film at -70°C. All lysates were first treated with preimmune serum as described above. Characterization of the anti-Fos and anti-Jun antibodies has been described elsewhere (21) .
Plasmids. (i) Reporter vectors. The AP-1 (OLIGO1 [46] )-containing plasmids were constructed by inserting OLIGO 1 (5'-TCGAAGCTATGACTCATCCGGTCGA-3') into the Sall site of pBLCAT 2 (29) . Constructs 1XTRE-and 3xTRE-tk-CAT have been described previously (2) . DSEtk-CAT was constructed by cloning an oligonucleotide containing the dyad symmetry element (DSE) of the c-fos promoter (-322 to -297 [56] ), 5'-CAGGATGTCCATATT AGGACATCTGC-3', into the Sall site of pBLCAT 2. pCH110, a plasmid containing the ,B-galactosidase coding sequences under the control of the simian virus 40 early promoter (14) , was purchased from Pharmacia.
(ii) Expression vectors. The complete coding regions of c-fos, fosB, fosBIsf and c-jun were cloned into the mammalian expression vector pMexNeo, in which the polylinker sequence is flanked by a Moloney murine sarcoma virus long terminal repeat and a polyadenylation signal of simian virus 40 (32) . The identity of all constructs was confirmed by sequencing.
Cell transfections. (i) Transient transfection. Transient transfections were performed by using a standard calcium phosphate coprecipitation technique (11) , with minor modifications. NIH 3T3 cells maintained in DMEM supplemented with 10% FCS were trypsinized and plated 24 h before transfection onto 100-mm dishes, so that at the time of transfection they were about 50% confluent. Two to three hours before transfection, cells were refed with fresh medium. Cells were exposed to the precipitate for 12 to 16 h, washed twice in PBS, and incubated for 36 to 48 h in 0.5% FCS before harvesting.
Typically, 2 jig of reporter plasmid and 3 ,ug of pCH110 (pSV2-p-galactosidase as an internal control [11] ) were used.
The amount of the expression vector pMexNeo (32) containing either c-fos, fosB, or fosB/sf is indicated in each case. The total amount of transfected DNA was always adjusted to 10 ,ug with pUC18.
For transrepression experiments, cells were exposed to the precipitate for 4 to 6 h, subjected to a 2-min glycerol shock (15%), and then washed twice in PBS. In this case, the total amount of transfected DNA was always adjusted to 15 jig with pUC18. After transfection, cells were made quiescent by incubation in DMEM containing 0.5% FCS for 36 to 48 h. Three hours before harvesting, cells were stimulated by addition of 20% FCS.
Chloramphenicol acetyltransferase (CAT) and 3-galactosidase activities were determined as described previously (11, 34) . The results were quantitated by cutting out and counting the spots in a scintillation counter. All results were standardized according to the internal levels of P-galactosidase and/or to protein content.
( the cloning protocol for NuSieve GTG agarose. The PCR fragments were sequenced as described previously (49) .
To obtain the complete fosBlsf, the PCR fragment in Bluescript KS' (plasmid 21R-A12) was digested with PstI and EcoRI, and the 630-bp PstI-EcoRI fragment containing the leucine zipper and 3' coding region of the short form was isolated. This fragment was ligated with a SalI-PstI fragment from thefosB cDNA clone. The ligation product was cloned into Bluescript KS' and pMexNeo vectors.
In vitro transcription and translation. c-fos, fosB, and c-jun vectors for in vitro transcription have been described previously (46) . fosBlsf was cloned into Bluescript KS'. In vitro transcription was carried out with the Boehringer transcription kit, using the T3 and T7 promoters and 7-methylguanosine capping structure according to the manufacturer's instructions. The c-fos, fosB, c-jun, and fosBlsf vectors were linearized with XbaI, EcoRV, SphI, and XbaI, respectively. In vitro translation in a rabbit reticulocyte lysate system was done with the Promega translation kit, using [35S]methionine as the label.
RESULTS
Existence of two forms of FosB. During the course of our studies on the induction of FosB following serum stimulation of Swiss 3T3 cells, we observed that in all cases two major bands that followed identical kinetics were immunoprecipitated by anti-FosB antibodies (Fig. 1A) . Of these, only the higher-molecular-size form (52 fied. Two important observations suggested to us that the 37-kDa protein was directly related to FosB. First, immunopurified anti-FosB antibodies preabsorbed against c-Fos and Fra-1, in order to diminish cross-reactivity with related molecules, recognized the 37-kDa protein, and second, the protein displayed a kinetic of induction identical to that of FosB. To further investigate the nature of the 37-kDa protein, we determined whether it was associated in vivo with some of the Jun proteins. For this purpose, serumstimulated Swiss 3T3 cells were labeled for 2 h with [35S]methionine, lysed under nondenaturing conditions, and then immunoprecipitated with anti-JunB antibodies, as JunB is the predominant Jun protein in these cells (21) . The immunocomplexes obtained were dissociated and reprecipitated with anti-JunB and anti-FosB antibodies. Both molecular forms of FosB were complexed with JunB, as shown by their coprecipitation with the anti-JunB antibody (Fig. 1B) . These experiments demonstrated that the 37-kDa protein was not a contamination and very unlikely the result of a crossreaction of the anti-FosB antibody with another member of the Fos family. Moreover, they show that the small-molecular-weight form was able to associate in vivo with JunB as efficiently as with FosB. As the 37-kDa protein could associate with JunB, we concluded that it had to contain an intact leucine zipper region since it is essential for the association of FosB with the Jun proteins (48) . This finding prompted us to investigate whether the fosB gene could give rise to two transcripts.
PCR analyses of total RNA from serum-stimulated fibroblasts using appropriate fosB primers show that indeed the fosB gene gives rise to two products, one of them lacking 140 nucleotides of the coding region. By comparing the sequences of the PCR products with that of the fosB gene, we determined that the short form of fosB, fosB/sf, lacks 140 nucleotides of exon 4 between nucleotides 4685 and 4825 of the fosB gene. The 5' and 3' deletion endpoints contain typical donor and acceptor splice sites, respectively (35) nucleotides, it codes for a protein of 237 amino acids, in contrast to the 338 amino acids of the complete form, as the result of an in-frame stop codon generated in the alternative splicing site. The size of the in vitro-translated FosB/SF protein is identical to that of the low-molecular-weight form immunoprecipitated with the anti-FosB antibody (Fig. 1C) . We also demonstrated that in vitro-translated FosB/SF not only can complex with c-Jun but also increases its DNA binding activity similarly to FosB (not shown). These results convinced us that the small-size band detected with the anti-FosB antibody in vivo is in fact FosB/SF. Similar results have been recently reported by Nakabeppu and Nathans (37) .
Transactivation by FosB and FosB/SF. To investigate whether FosB and FosB/SF differ in their capacity to transactivate, we cotransfected NIH 3T3 cells with pMexNeofosB or pMexNeo-fosB/sf. NIH 3T3 cells were chosen because they represent a model for studying the role of AP-1 proteins following mitogen activation. Reporter constructs containing different AP-1 binding sites, OLIGO1-and TREtk-CAT, were used since we had previously shown that the nucleotides flanking the AP-1 consensus sequence have a strong effect in the binding of Jun and Jun:Fos complexes (46) . Our initial experiments demonstrated that pMexNeofosB did not require the cotransfection of pMexNeo-c-jun to activate the transcription of an AP-1-CAT construct in NIH 3T3 cells, possibly because of the high levels of Jun proteins present; therefore, we performed all transfections in the absence of a c-Jun-expressing vector. Transfection offosB and fosBIsf showed that both products can activate transcription of OLIGO1-and TRE-tk-CAT constructs (Fig. 2) . Activation was observed for a single copy of AP-1 as well as when AP-1 was cloned in an oligomerized form. Single-copy OLIGO1 and TRE are weaker in their activation, and both forms of FosB similarly increased their transcription by 1.5- to 3-fold. However, when OLIGO1 and TRE were used in an oligomerized form, a strong activation of CAT transcription was observed with the two FosB forms, although FosB/SF was a weaker activator. FosB induced CAT expression on average 15-to 20-fold, while FosB/SF increased it only 5-to 8-fold. The highest activation was obtained with the 5xOLIGO1-tk-CAT construct; therefore, it was selected for further studies.
To better compare the activities of FosB and FosB/SF, different concentrations of the corresponding expression vectors were used for transfections. As shown in Fig. 3 , the activation of CAT expression correlates with the amount of FosB-, FosB/SF-, and c-Fos-expressing vector transfected. A significant induction of 5 x OLIGO1-tk-CAT could be detected when only 0.05 ,ug of fosB or fosBlsf expression vector was used. Transfection offosB consistently gave the strongest activation, enhancing transcription two-to threefold more than did fosB/sf and c-fos. These differences in activity could partly be due to differences in the expression of the Fos proteins. We 4. alone (Fig. 4) . However, when the amount offosBlsf transfected was fourfold higher than that of fosB, the final induction of CAT expression was similar to that observed upon transfection of fosBIsf alone, suggesting that FosB is subject to strong competition by FosB/SF under these conditions. This result was expected in part because both FosB and FosB/SF can efficiently interact with Jun proteins; therefore, when FosB/SF is much more abundant than FosB, the majority of the Jun molecules in the cell will be complexed with FosB/SF. Surprisingly, cotransfection of fosBIsf with c-fos seemed to have no effect on c-Fos activity; the final induction of CAT expression was similar to that observed when c-fos was transfected alone.
Transactivation by FosB/SF in stable transfectants. To confirm that FosB/SF could activate transcription, we decided to generate NIH 3T3 cell lines constitutively expressing FosB and FosB/SF and compare their capacities to induce expression of plasmid 5 x OLIGO1-tk-CAT. The transfected clones selected by neomycin resistance were screened for FosB and FosB/SF expression by indirect immunofluorescence using a specific anti-FosB antibody. Clones presenting a homogeneous population of cells expressing high levels of the proteins were chosen for further studies. Transfection of these clones with different concentrations of plasmid 5xOLIGO1-tk-CAT showed that both FosB-and FosB/SF-expressing cells induced CAT expression 2-to 10-fold more than did control NIH 3T3 cells, depending on the concentration of reporter plasmid used, confirming our results for transient expression assays (Fig.  5) .
We further demonstrated that the increase in transcription observed in FosB-and FosB/SF-expressing cells correlates with an increase in the AP-1 binding activity present in the cells as determined by gel retardation assays. The AP-1 binding activity detected in nuclear extracts from FosB-and FosB/SF-expressing cells was three to five times higher than in control cells (not shown).
FosB/SF does not repress DSE induction. Several lines of evidence indicate that cFos can repress its own expression through the DSE (20, 28, 41, 50, 53) and the expression of other immediate-early genes via CArG elements (10) . It also has been demonstrated that the 27 C-terminal amino acids of c-Fos which are conserved in the Fos family are essential for this repression (10, 55) . Therefore, as FosB/SF is missing this region, we found it of interest to determine whether this protein was able to repress the expression of a reporter gene driven by the c-fos DSE. NIH 3T3 cells were cotransfected with plasmid DSE-tk-CAT and a pMexNeo plasmid containing c-fos, fosB, orfosBlsf and then incubated for 36 to 48 h in 0.5% FCS before stimulation with 20% FCS for 3 to 4 h.
Expression of c-Fos reduced the activation of the DSE by serum approximately threefold (Fig. 6) . Similarly to c-Fos, expression of FosB inhibited induction of the DSE threefold. However, FosB/SF not only did not repress activation of the DSE but consistently enhanced its activation, possibly by competing with the intracellular Fos proteins induced by serum. These results confirm and extend the previous observations that the conserved C-terminal amino acids of Fos proteins are essential for repression.
Effect of FosB/SF on cell growth. The finding that FosB/SF stimulates transcription to a lesser extent than does FosB and that it can downmodulate the activity of the latter prompted us to investigate whether FosB/SF could act as a negative modulator in cell proliferation. For this purpose, three stable transfectants of NIH 3T3 cells constitutively expressing FosB/SF were used. As pressed mainly during the Go-to-G1 transition, we determined the capacity of quiescent FosB/SF-expressing clones to enter the cell cycle following serum stimulation. Confluent cultures of different FosB/SF-expressing clones were rendered quiescent by incubation in 0.5% FCS for 48 h before stimulation with different serum concentrations. The capacity to enter the cell cycle was determined by monitoring the percentage of cells in DNA synthesis after 24 h of stimulation. The independent FosB/SF-expressing clones compared with control NIH 3T3 cells show a similar capacity to enter the S phase at all concentrations of serum used (not shown). It is important to note that in these clones the expression of FosB/SF compared with FosB is at least 5-to 10-fold higher than the maximum transient expression observed 2 h following serum stimulation of NIH 3T3 cells.
Since high levels of FosB/SF expression did not have a significant inhibitory effect on the induction of cell proliferation, we decided to investigate whether the protein could affect cell growth in asynchronous cultures. FosB/SF-expressing clones were plated at similar cell densities and grown in media with different serum concentrations for 6 days. Their growth rates were determined by daily counting of the cells. No significant differences in the rates of proliferation of the FosB/SF-expressing clones and control NIH 3T3 cells were found at any serum concentration used (Fig.  7) Complexes between FosB/SF and the different Jun proteins can be readily detected in nondenatured cellular lysates of transfected cells (Fig. 8B) . Furthermore, considering the amount of c-Jun, JunB, and JunD that is coprecipitated with FosB/SF and their total cellular amount, it is possible to infer that more than 80% of the c-Jun, JunB, and JunD molecules are associated with FosB/SF in these cells under growing conditions. This view was further confirmed by the observation that in the supernatant of the cellular lysates immunoprecipitated with the anti-FosB antibody under nondenaturing conditions, only a small fraction of c-Jun, JunB, and JunD was present (Fig. 8B) (46) . Since the two forms of FosB have similar activities in fibroblasts, the biological significance of FosB/SF in these cells is poorly understood.
We have shown that FosB/SF when expressed in excess to FosB can downmodulate the activity of FosB and that the activation level obtained is similar to that of FosB/SF alone. This finding indicates that the two FosB molecules are part of the same activating pathway and compete for common effectors. In contrast to the competition observed between both forms of FosB, c-Fos seems to have no effect, suggesting that although in NIH 3T3 cells FosB and c-Fos share common effectors, their activation may proceed via slightly different pathways.
The observation that FosB/SF is less active than FosB, and the fact that it has lost the capacity to transrepress, indicates that the 101 amino acids of the C terminus contain an activation domain that is necessary but not essential for FosB transcriptional activity and agrees with the previous observations that the last 27 C-terminal amino acids which are conserved in the Fos family are required for transrepression (10, 55) . The clear identification of the putative activation domain present in the C-terminal region will require further studies.
Although FosB/SF is a weaker transactivator than FosB and can compete for common effectors, the experiments with the stable transfectants demonstrate that a 5-to 10-fold increase in FosB/SF over the normal cellular level expressed following serum stimulation does not diminish the capacity of resting cells to enter the cell cycle. Furthermore, the growth rate of exponentially growing cells constitutively expressing high levels of FosB/SF is similar to that of their control counterpart. This finding, together with our finding that FosB/SF is complexed with the Jun proteins in growing cells, strongly suggests that FosB/SF does not have a negative effect on normal cell growth.
It has been previously demonstrated by using antisense c-fos expression (39) and microinjection of anti-Fos antibodies (42) that the activity of c-Fos is required for resting cells to enter the cell cycle and for cell cycle progression of exponentially growing cells. Furthermore, we have shown that microinjection of antibodies against any single member of the Jun family significantly inhibits the entrance to the cell cycle of resting cells and that Jun and Fos protein activity is required for cell cycle progression (22) . These results, together with the findings presented in this report, led us to conclude that FosB/SF in NIH 3T3 cells displays a significant transcriptional activity; otherwise, its overexpression would have a detrimental effect on cell proliferation.
Previous studies concerning the structure and function of v-fos protein demonstrated that truncation of more than 160 amino acids corresponding to the C terminus of c-Fos caused only a small reduction in focus formation (19, 56) . Furthermore, a region of the v-Fos protein, corresponding to c-Fos amino acids Met-111 to Ile-206, conserved its ability to transform and to stimulate cell proliferation (56) . This region, which is highly conserved among the different Fos proteins, is present in FosB/SF. The identity of FosB and c-Fos in this 85-amino-acid segment is 78% and, if conservative changes are considered, is over 90%; therefore, it would be expected that FosB/SF when associated with Jun proteins will still generate an active transcription complex. Accordingly, we have recently demonstrated that overexpression of FosB/SF in Rat-lA cells increases the ability of the cells to grow in semisolid medium and to produce tumors in BALB/c (nulnu) mice, although to a lesser extent than does FosB (23).
In conclusion, the different lines of evidence presented in this report demonstrate that FosB/SF functions as a transactivator and that it is not a negative regulator of normal cell proliferation in fibroblasts.
